题名

反覆胸痛的惡性肋膜間皮癌個案報告

并列篇名

A Case Report of Malignant Mesothelioma Presenting with Recurrent Chest Pain

DOI

10.3966/168232812019062902005

作者

蕭文棋(Wen-Chi Hsiao);李國任(Kuo-Jen Li);林佳臻(Chia-Chen Lin);陳民虹(Ming-Hung Chen)

关键词

石綿 ; 胸痛 ; 肋膜積液 ; 惡性肋膜間皮瘤 ; 職業暴露 ; asbestos ; chest pain ; malignant pleural mesothelioma ; occupational exposure ; pleural effusion

期刊名称

台灣家庭醫學雜誌

卷期/出版年月

29卷2期(2019 / 06 / 01)

页次

98 - 104

内容语文

繁體中文

中文摘要

惡性肋膜間皮癌在台灣的發生率不高,若忽略了個案的職業史及暴露史,不容易被納入胸痛的鑑別診斷。本文報告59歲男性個案,從事以石綿為隔熱材質的鍋爐製造業,將近兩年以反覆發作的胸痛求診,雖在病程初期即出現單側肋膜積液,但其積液不像多數的惡性肋膜積液持續地增加而是反覆地出現,再加上其臨床表現有許多發炎症候,也未詢問職業暴露史,因此病程中多以感染性疾病來治療,直至腫瘤快速生長時才安排組織學切片,確診時已是第三期的惡性肋膜間皮癌。本個案提醒基層醫師不能忽略職業史及暴露史,若有石綿暴露且病人出現反覆發作性的胸痛或肋膜積液,雖不是典型地持續增加,也應積極地安排進一步檢查。

英文摘要

Due to its low incidence in Taiwan, malignant pleural mesothelioma is seldom considered by physicians in their differential diagnosis of chest pain, especially when information about patients' occupation and asbestos-exposure history are not obtained. This article presents a 59-year-old male, a former boiler worker with high asbestos exposure, who had recurrent chest pain with some infectious symptoms and signs in the past two years. In spite of the occurrence of unilateral pleural effusion in the early stage, biopsy was not performed to confirm mesothelioma until it rapidly progressed to stage III tumor. The physicians did not inquire into the patient's asbestos exposure history, and his pleural effusion appeared to be remitting-relapsing, instead of the persistent and increasing manner typical of malignant pleural mesothelioma. Both factors led to the delay in his diagnosis. This case reminds physicians of the need to understand patients' occupational and exposure history. Aggressive investigation need to be arranged for high asbestos exposure patients presenting with recurrent chest pain or remitting-relapsing pleural effusion.

主题分类 醫藥衛生 > 社會醫學
参考文献
  1. 蕭汎如(2018)。石綿暴露工作者的職業健檢:職業醫學專科醫師的觀點。臺灣衛誌,37,24-33。
    連結:
  2. Asbestos(2012).IARC monographs on the evaluation of carcinogenic risks to humans.Lyon, France:IARC=International Agency for Research on Cancer.
  3. Bianchi, C,Bianchi, T(2014).Global mesothelioma epidemic: trend and features.Indian J Occup Environ Med,18,82-88.
  4. Buntinx, F,Knockaert, D,Bruyninckx, R(2001).Chest pain in general practice or in the hospital emergency department: is it the same?.Fam Pract,18,586-589.
  5. Cui, A,Jin, XG,Zhai, K,Tong, ZH,Shi, HZ(2014).Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.BMJ Open,4,e004145.
  6. Hammond, EC,Selikoff, IJ,Seidman, H(1979).Asbestos exposure, cigarette smoking and death rates.Ann N Y Acad Sci,330,473-490.
  7. Herndon, JE,Green, MR,Chahinian, AP,Corson, JM,Suzuki, Y,Vogelzang, NJ(1998).Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.Chest,113,723-731.
  8. Hjerpe, A,Ascoli, V,Bedrossian, CW(2015).Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma.Acta Cytol,59,2-16.
  9. Kost, RG,Straus, SE(1996).Postherpetic neuralgia - pathogenesis, treatment, and prevention.N Engl J Med,335,32-42.
  10. Lin, RT,Chang, YY,Wang, JD,Lee, LJ(2019).Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.J Formos Med Assoc,118(1 Pt 3),463-470.
  11. Muruganandan, S,Fitzgerald, DB,Lee, YCG(2018).Malignant pleural mesothelioma presenting with remitting–relapsing pleural effusions: report of two cases.Respirol Case Rep,6,1-3.
  12. Neumann, V,Löseke, S,Nowak, D,Herth, FJ,Tannapfel, A(2013).Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.Dtsch Arztebl Int,110,319-326.
  13. O'reilly, KM,Mclaughlin, AM,Beckett, WS,Sime, PJ(2007).Asbestos-related lung disease.Am Fam Physician,75,683-688.
  14. Robinson, BW,Musk, AW,Lake, RA(2005).Malignant mesothelioma.Lancet,366,397-408.
  15. Rusch, VW,Giroux, D,Kennedy, C(2012).Initial analysis of the international association for the study of lung cancer mesothelioma database.J Thorac Oncol,7,1631-1639.
  16. Wang, ZJ,Reddy, GP,Gotway, MB(2004).Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.Radiographics,24,105-119.
  17. 行政院環境保護署:環保署提前全面禁用石綿之時程。108年1月10日,取自https://enews.epa.gov.tw/enews/fact_Newsdetail.asp?InputTime=1060510120308
  18. 李俊賢(2016)。石綿的健康危害與台灣現況。勞動者,187,30-39。
  19. 勞動部職業安全衛生署(2011)。勞動部職業安全衛生署:石綿(包括含石綿的滑石)引起之職業性癌症診斷認定參考指引-1惡性間皮細胞瘤。100年修訂1版。勞動部職業安全衛生署,2011。
  20. 鄭雅文(2016).石綿宣導手冊.新北市:新北市政府勞動檢查處.
  21. 蕭汎如,鄭雅文,王榮德(2016)。石綿疾病的補償政策:日本、韓國與香港經驗。勞動者,187,20-29。
  22. 藍郁青(2018).職場石綿暴露與勞工職業病調查研究.新北市:勞動部勞研所.